Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass

Gastric bypass (GB) is an effective treatment for those who are morbidly obese with coexisting type 2 diabetes mellitus (T2DM) or non-alcoholic fatty liver disease (NAFLD). Fibroblast growth factors (FGFs) are involved in the regulation of energy metabolism. We investigated the roles of FGF 19, FGF...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nutrients 2022-02, Vol.14 (3), p.645
Hauptverfasser:	Guo, Jiun-Yu, Chen, Hsin-Hung, Lee, Wei-Jei, Chen, Shu-Chun, Lee, Shou-Dong, Chen, Chih-Yen
Format:	Artikel
Sprache:	eng
Schlagworte:	Bile Biomarkers Body fat Body mass index Cholesterol Creatinine Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - metabolism Energy metabolism Fatty liver Fibroblast growth factors Fibroblast Growth Factors - metabolism Fibroblasts Gastric Bypass Gastrointestinal surgery Glucose Growth factors Hemoglobin Humans Insulin resistance Laboratories Liver Liver diseases Metabolism Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - metabolism Obesity Obesity, Morbid - complications Obesity, Morbid - metabolism Obesity, Morbid - surgery Ostomy Patients Plasma Proteins Remission Steatosis Substance abuse treatment Surgery Surgical techniques Triglycerides Tuberculosis Weight control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!